Heart Failure With Improved Ejection Fraction: Clinical Characteristics, Correlates of Recovery, and Survival: Results From the Valsartan Heart Failure Trial [Original Article]
Conclusions—
Our data support HFiEF as a stratum of HF with reduced ejection fraction with a more favorable outcome, which occurs in a minority of patients with HF with reduced ejection fraction who have a lower prevalence of ischemic heart disease, a less severe hemodynamic, biomarker, and neurohormonal profile, and who are treated with a more intense HF medication regimen.
Clinical Trial Registration—
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00336336.
Source: Circulation: Heart Failure - Category: Cardiology Authors: Florea, V. G., Rector, T. S., Anand, I. S., Cohn, J. N. Tags: Heart Failure, Remodeling Original Article Source Type: research
More News: Beta-Blockers | Cardiology | Clinical Trials | Diovan | Heart | Heart Disease | Heart Failure | Neurology